18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR

/PRNewswire/ -- 18-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Clinical Trial at VIVA21. The objective...

Related Keywords

Singapore , Richard Kenyon , Tang Tjun Yip , Ma Med Alliance , Cell Adherent Technology , Hospital Department Of Vascular Surgery , Singapore General Hospital , Associate Professors , Chong Tze Tec , Senior Consultant , Peripheral Artery Disease , Medalliance Chairman , Selution Sirolimus Coated Balloon , Medalliance ,